Quality Control Considerations for Fluorescence In Situ Hybridisation of Paraffin-Embedded Pathology Specimens in a Diagnostic Laboratory Environment by Duffy, Lisa et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 21
Quality Control Considerations for
Fluorescence In Situ Hybridisation of
Paraffin-Embedded Pathology Specimens
in a Diagnostic Laboratory Environment
Lisa Duffy, Liangtao Zhang, Donald R. Love and
Alice M. George
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/51266
1. Introduction
Paraffin FISH testing is the application of the fluorescence in situ hybridisation (FISH) meth‐
odology to formalin fixed paraffin embedded sections (FFPE), and has proven a powerful
tool for both histopathologists and cytogeneticists. Pathologists use the method to confirm
or exclude a histological diagnosis, to differentiate between tumour subtypes, or as a confir‐
matory tool where the tissue morphology is poor or the immunohistochemistry (IHC) stain‐
ing is uninformative [1]. Similarly, cytogeneticists find it useful when the tissue sample is
insufficient or unsatisfactory for conventional culture methods, or when such methods fail
to yield a result. The method can also be used to confirm abnormalities found in other tissue
samples. Paraffin testing has a further advantage over conventional cytogenetic and molecu‐
lar testing methods, as it can localize the anomaly within specific cells or tissue areas, and
this provides the ability to study anomalies at a single cell level [2,3], unlike DNA techni‐
ques that pool DNA from hundreds of different cells [1,3].
Compared to FISH testing on conventional suspension samples (Figure 1), paraffin FISH can
be labour intensive and highly variable due to differing fixation times between samples and
referring histology labs, and the interpretation may be limited due to truncation of signal
and overlapping cells [1,4].
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Figure 1. A comparison of the paraffin pre-treatment process with the conventional FISH pre-treatment process on
suspension semples.
For these reasons, it must be considered separately from the conventional suspension FISH
method, and while it can be used as either a stand-alone technique, or an adjunct to conven‐
tional cytogenetics techniques [5], it must be noted that due to the use of interphase nuclei, a
prior knowledge of the anomaly of interest is required.
Figure 2. Errors that occur during the paraffin pre-treatment process.
The basic premise of the method involves establishing the area of interest for testing on the H+E
stained pathology slide, and transferring this area to an unstained paraffin slide, which is then
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pretreated, probed and co-denatured using the traditional FISH methodology [6,7]. However,
one of the most crucial factors for paraffin analysis is the assessment of the correct target area
before beginning the procedure – without this, an erroneous result may occur (Figure 2), which
may be costly to patients if it results in the appropriate treatment being with held [1].
For this reason, robust internal and external quality control procedures are required for di‐
agnostic paraffin FISH testing and the exclusion of non-target tissue before analysis decreas‐
es the likelihood of an incorrect result due to an analysis error [1]. This protocol therefore
aims to provide a guide to some of the considerations and troubleshooting that are necessa‐
ry when using the method for diagnostic medical testing. It is adapted from the method
used by the Diagnostic Genetics Department, LabPlus at Auckland City Hospital, New Zea‐
land. There are a number of variations to the basic FISH method that can be used depending
on the nature and number of samples being processed, and new technology has also been
developed to automate the process (Xmatrix, Abbott Molecular). In this protocol however,
we have suggested extra steps that are designed to help improve the quality of the testing
procedure for diagnostic use. Probes used for diagnostic testing are commercially available
and may be downloaded and gathered from the websites of companies such as Abbott Mo‐
lecular, Cytocell, Zytovision or Kreatech Diagnostics.
2. Method
One slide (2-5 micron thickness usually) is needed per probe or probe set, and if a haematoxy‐
lin and eosin (H+E) slide is not provided by pathologists, an extra slide must also go through
the deparaffinisation steps before staining with the Shandon Rapid-Chrome™ Frozen Section
Staining kit (alternatively the individual stain kit components can be made from powder).
Figure 3. Slide pretreatment steps for paraffin FISH. (A) Appearance of unstaind paraffin slides after aging in a 60ºC
oven - note melted or "bubbled" appearance. (B) Unstained paraffin slides and after the pre-treatment steps.
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1. Deparaffinisation (approx. 60 minutes); see Figure 3
a. Leave slide/s on the hotplate/in the oven at approximately 65°C for 30-60 minutes for
aging (Figure 3).
b. Perform deparaffinization by placing slide/s in xylene for at least 10 minutes in the
fume hood, with intermittent shaking.
c. Rehydrate slide/s by placing them for 2 minutes in each of 100%, 80%, and 70% ethanol
solutions, followed by deionised water at room temperature.
2. Haemotoxylin and Eosin (H+E) slides; see Figure 4
Figure 4. A haemotoxylin and eosin (H+E) stained slide with the target area for analysis marked by a pathologist.
a. Take rehydrated slide/s and stain using the Shandon Rapid-Chrome™ Frozen Section
Staining kit and mount the slide using Shandon Mount.
b. Leave slides on the hotplate for at least 30 min to dry the mountant.
c. Check slides for stain quality under a light microscope.
d. Take slide/s to pathologist for marking (Figure 5).
3. Heat Pre-treatment (approx. 30 minutes)
a. Add 35μl of heat pre-treatment solution (Invitrogen Tissue Pre-treatment Kit) to the
slide/s,  cover with a 22x22mm (or bigger sized cover slip)  glass cover slip and seal
with rubber cement. Alternatively slides can be heat-pre-treated in coplin Jar at 95°C
or pressure cooker.
b. Heat slide/s on the thermal cycler for 15-60 minutes at 95°C (The time is dependent on
the type of tissues and length of formalin fixation).
Latest Research into Quality Control472
c. On completion, immerse slide/s with cover slip in deionised water to cool down and
gently remove the cover slip.
d. Wash briefly  in  a  coplin  jar  of  deionised water  at  room temperature  and drain  off
excessive water.
4. Enzyme Digestion (approx. 40 minutes).
a. Add an appropriate amount (~15μl) of enzyme reagent (Invitrogen Tissue Pre-treat‐
ment Kit) to the slide/s, depending on the size of hybridisation area, and cover with a
square of parafilm.
b. Incubate slide/s for 15-45 minutes in a humidified chamber at 37°C (This time is de‐
pendent on the type of tumours and length of formalin fixation).
c. Remove  cover  slip/s  and  wash  briefly  in  a  coplin  jar  of  deionised  water  at  room
temperature.
d. Dehydrate slide/s for 2 minutes each in each of 70%, 80% and 100% ethanol solutions
and air dry at room temperature. Please note that a different ethanol series is used for
the dehydration steps to avoid reagent contamination issues.
e. Check the tissue morphology of the pre-treated slide looks the same as that of the H+E.
f. The pre-treated paraffin slide/s should then be carefully matched against the marked
H&E slide/s, and the area for testing transferred to the pre-treated slide/s using a mark‐
er pen initially, followed by the diamond-tipped engraver. This means that the area can
still be visualised after the post-wash steps.
Figure 5. Haemotoxylin and eosin (H+E) stained slides marked with the target area for analysis.  This reduces the
volume of  probe necessary  and ensures  that  non-target  tissue  is  excluded as  much as  possible  before  the  FISH
analysis procedure.
Quality Control Considerations for Fluorescence In Situ Hybridisation of Paraffin-Embedded Pathology Specimens
http://dx.doi.org/10.5772/51266
473
Figure 6. Transfer of target area for analysis from the H+E slide to the pre-treated FISH slide prior to the probing steps.
Figure 7. Engraving of target area on to the pre-treated paraffin FISH slide. (A) Draw target area onto bottom of slide
with fix-resistant pen. (B & C) Engrave marked area onto bottom of slide using diamond-tipped engraver to keep area
visible after post-wash steps.
5. Probe preparation (approx. 10 minutes)
Use Ready-To-Use probes or refer to the probe preparation protocol outlined by the
manufacturer.
6. Co-denaturation and hybridization (approx. 25 minutes)
a. Apply an appropriate amount (2-10μl) of probe mix to the hybridization site marked on
each slide, depending on the size of cover slip being used, and seal with rubber cement.
Leave the slide/s in the incubator or in a drawer at room temperature for a few minutes
to allow the rubber cement to dry before placing them in the thermal cycler.
b. Denature slide/s together with probe mix for 10-20 min at 85°C or 5-10min at 95°C.
c. After co-denaturation, slide/s may be placed in a humidified box in the incubator at
37°C for at least 12-16 hours, usually no more than 72 hours.
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7. Post Hybridization Wash (5 Minutes)
a. Briefly soak slide/s in 2xSSC and gently remove rubber cement.
b. Wash slide/s in 0.4xSSC/0.03% Tween 20 (or NP40) at 72°C for 2 min.
c. Place slide/s in 2xSSC/0.01% Tween 20 (or NP40) for 1 min.
d. Briefly drain slide/s, apply DAPI counter stain and put cover slip on.
e. Visualize FISHed-slide/s under fluorescence microscope.
When using indirectly labelled commercial probes that require antibody detection, signal
detection must be done according to the manufacturer’s instructions.
8. Analysis and interpretation; see Figure 8.
a. With a pathologist’s consultation, check the H+E slide on a transmitted light microscope
to assess whether the sample contains a mixture of cell types, as this may affect the in‐
terpretation of the FISH signal pattern.
b. Check the paraffin FISH slide on a fluorescence microscope using the 10x objective to
ensure the area marked on the slide approximately matches that on the H+E slide.
c. Using two observers, analyse a minimum of at least 8 representative sites within the
marked region (a minimum of 4 different areas per observer), scoring only cells that
show both the target and control loci.  Analysis of areas of areas where the cells are
not overlapped is preferable, and a third analyst is required where there is discord‐
ance between two observers.
Figure 8. Analysis principles for paraffin FISH slides.
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3. Troubleshooting
Problem: Unclear whether slides have been aged before arrival, as repeating this step may
decrease the hybridization efficiency of the probe.
[Step 1]
Solution:  Although some waxes do not  change in appearance,  pre-aged slides  generally
have a bubbled or melted appearance of the wax compared to the smooth appearance of
non-aged slides in general (N.B: some wax types do not change in appearance so this is
a rule of thumb only).
Problem: The use of  xylene to remove the wax from around the sample is  not  ideal  as
xylol is highly toxic.
[Step 1]
Solution: An alternative to xylene is HemoDe from Scientific Safety Solvents.
Problem: Finding that the wrong tissue was sent by the referring laboratory.
[Step 2]
Solution: Ask for a copy of the pathology report to be sent with all samples, and get patholo‐
gists to ring the referring laboratory to request the appropriate sample for testing.
Problem:  Incomplete  staining of  the  H+E slide  causing correct  target  area  to  be  missed
by pathologist.
[Step 2]
Solution: Slides should be quality checked before taking them to a pathologist. Check the stain
by eye to see if there are obvious colour differences across the slide – if one of the stains has
been missed in an area it will appear either a dull purple (eosin missed) or a dull pink (haema‐
toxylin missed or there is a problem with the pH of the bluing reagent) compared to the rest of
slide. If there are any doubts, ask a histopathology technologist for assistance.
Problem: Cover slip moves after the slide has been marked because mountant is not com‐
pletely hardened. This causes the target area to move.
[Step 2]
Solution: Leave the slides on the hotplate for a longer period of time, or change mountant to
a faster drying version such as Entellan (Note: it is not possible to remove the Entellan with
methanol after it has been cover slipped, hence why DPX is the preferred mountant).
The Rapid-Chrome™ Frozen Section Staining kit uses Shandon Mount; however alterna‐
tives such as Entellan are available.
Problem: Disappearance of tissue on slide during dehydration steps.
[Steps 3 and 4]
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Solution: The ethanol series (in step 1) is necessary to rehydrate the tissue for the enzyme
solution to act on, and may cause the tissue to become translucent, however it will become
white again once the slide is dehydrated.
Problem: Scratching or loss of tissue during washing steps. Small tissue samples (e.g. core
biopsies) may become fragile during the pretreatment steps and fall off the slide.
[Steps 3 and 4]
Solution: As the tissue becomes soft during pre-treatment it may easily fall off or get scratch‐
ed; coplin jars of deionised water can be used to dip slides into rather than the more aggres‐
sive use of squirter bottles or running tap water (do not leave the pre treated slide in water
for a long time, especially for a core biopsy or a tiny sample). The size of the tissue gives a
good indication as to the fragility of the tissue, so this should be taken into account before
beginning the pre treatment steps. Increasing the ageing step may also help to fix the tissue
to the slide better, although it may also decrease the hybridization efficiency of the probe to
the sample. Alternatively, skipping the heat pretreatment step and doing a reduced enzyme
treatment on the sample may combat this.
Problem: The tissue does not look the same as the H+E slide after dehydration steps.
[Step 4]
Solution: This can either be due to loss of tissue during pretreatment or different cuts
through the tissue block. Untreated slides should be closely examined to find one that ap‐
pears to match the pretreated slide and a new H+E slide created using this slide. See also
steps for reducing the loss of tissue during pretreatment.
Problem: Transfer of area is difficult due to a slight difference in the morphology of the tis‐
sue in different layers of the tissue section, or different orientation of tissue on pre-treated
slide to that of the H+E slide.
[Step 4]
Solution: If the morphology of tissue on the pre-treated slide looks different to that of the H
+E slide, check it against the remaining untreated slides to see if it looks like tissue has been
lost during the pre-treatment procedure. If tissue has been lost, simply start the procedure
over again with a new slide. If the morphology of the tissue appears different between the
untreated slides, ask a pathologist for help selecting an appropriate slide to pre-treat, and
try to find two similar untreated slides. Pre-treat one and make the other into an H+E slide
to allow for more accurate marking.
Problem: There is more than one target area marked on slide – is more probe required?
[Step 4 and 5]
Solution: Assess the size of the areas – if there are several small areas, the total volume of
probe does not need to be increased, simply aliquot the volume of probe equally over the
different areas and place a small cover slip over each. More than one aliquot of probe is only
required if the areas are greater than can be covered by a 13mm diameter cover slip.
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Problem: The hybridisation buffer for a probe runs out.
[Step 5]
Solution: As hybridisation buffers are all fairly similar, it is fine to use the buffer of similar
probe as a substitution. Alternatively, hybridization mix can be made up:
Hybridization mix
(10% dextran sulphate, 50% formamide in 2xSSC, 0.1% SDS, pH 7.0)
1. Mix 12.5ml formamide, 2.5ml 20xSSC pH7.0 and 10ml MilliQ water. Adjust pH to 7.0
with HCl then transfer to a 50ml Falcon tube.
2. Add  2.5mg  dextran  sulphate  and  place  on  a  roller  mixer  at  room  temperature  for
1-2 hours.
3. Add 25μl Tween 20 and invert to mix.
4. Aliquot  500μl  into  sterile  eppendorf  tubes.  Store  at  -20°C  and  use  a  fresh  aliquot
each time.
Problem: A thermal cycler is not available for use.
[Step 6]
Solution: Denaturation of the slide(s) can be done separately using 70% formamide/2xSSC, as it
gives better quality denaturation although the downside is that it is highly toxic. The hybridi‐
sation steps can also be done adequately in a programmable system (e.g. Thermobyte).
Problem: The cover slip is hard to remove before the post wash steps.
[Step 7]
Solution: Place slide in 2xSSC solution and agitate gently after removing the rubber cement,
and then remove cover slip. If the cover slip is still stuck to slide, slide the blade of a scalpel un‐
der one corner of the slide and lift gently before immersing the slide in a 2xSSC solution and ag‐
itating it gently. This may need to be repeated several times if the cover slip remains stuck.
Problem: Weak or patchy signal quality.
[Step 8]
Solution: This can be difficult to fix, as it primarily occurs as a result of poor handling and
fixation of tissue prior to receiving the sample for FISH testing [8,9]. Different tissue samples
may require the pretreatment times to be varied [10]. The heat pretreatment buffer prepares
the tissue for the enzyme to act on and the enzyme degrades the cellular material away from
the DNA, in order to allow the probe to anneal to the chromatin. Variation of either or both
these times is effective, and the steps may be repeated on the probed slide to reduce the
need for lengthy pretreatment times on a new slide. Bone samples such as trephines may
show poor hybridization efficiency of the probe, and require hydrogen chloride treatment,
unless the sample has already been decalcified prior to arrival.
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Poor signal quality may also be a result of incorrect post wash stringency. There is an alter‐
native wash technique that uses 50% formamide/2xSSC to increase the stringency of the
wash. However, this is not always ideal, as it significantly increases the length of the post
wash, and also uses formamide which is extremely toxic [11].
Problem: High levels of cross hybridization due to non-specific binding of probes.
[Step 8]
Solution: This is due to incorrect stringency of the post wash [1]. For a quick fix, slides can
be rewashed using the quick wash procedure reported here, or alternatively washing at a
higher temperature or use of a different post wash procedure can be tried [11].
Problem: Cells only show one signal colour.
[Step 8]
Solution: Only cells showing both the control and target loci should be scored (e.g. 2R2G), so
if both the control probe and the probe for the region of interest are on the same chromo‐
some, it is most likely to be due to poor hybridisation of one of the probes. First check to see
using single colour filters whether the signal colour is present but weak – if it is, repeat the
pre-treatment and hybridisation steps again on the same slide (for a shorter time e.g. 15/15
buffer: enzyme treatment).
Problem: Using an indirectly labeled probe and can’t get a good signal quality.
[Step 8]
Solution: In most cases, amplification with only a primary antibody is necessary, and further
amplification can also increase the level of background on the slide(s). However if the signal
is not bright enough, carefully remove the cover slip, rinse slide in 1xPBS (or SSC) and per‐
form further amplification steps with secondary or tertiary antibodies as many times as nec‐
essary. After adding each antibody, slides should be covered with parafilm and incubated in
a humidified chamber at 37°C for 5 minutes before being washed in 4xSSC/0.05% Tween20
for 2 minutes. Then mount with 8μl Vectashield antifade solution with DAPI.
Problem: Distinguishing between real signal and background or ‘rubbish’ on slide.
[Step 8]
Solution: Look at the signal intensity on single colour filters – rubbish generally appears to
be brighter and shinier compared to real signals, and background will appear fuzzy and in‐
distinct compared to real signal. High background may be due to the slides not being prop‐
erly sealed with rubber cement during the pretreatment steps, as this allows the solution to
evaporate and the tissue to dry out.
Problem: High background on the slides when analyzing.
[Step 8]
Solution: High background may be due to insufficient removal of material during the pre‐
treatment steps. With high case numbers, solutions can become contaminated, therefore the
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solutions in the pretreatment steps need to be changed regularly, and it pays to have an ad‐
ditional coplin jar of 100% ethanol to dip the slides into after the xylol step in order to re‐
duce contamination from the xylol solution. Alternatively, background may be due to the
cover slip not being sealed properly during the pretreatment and co-denaturation steps,
causing the tissue to dry out. By placing the slide in the incubator to allow the rubber ce‐
ment to dry before these steps, this effect can be reduced. The use of a glass coverslip rather
than a plastic coverslip also helps, as plastic acts as an insulator, and therefore will hold the
temperature and increase the drying of the tissue.
The use of detergents in the post wash steps also helps to solubilize proteins, and if Tween20
is not effective, then NP-40 can also be used.
Problem: There is a mixed cell population in the marked target area (e.g. Tumour cells with
non-target lymphocytes also present); see Figure 9.
Figure 9. The analysis of slides with mixed tissue populations.
[Step 8]
Solution: Check the H+E slide first before analysing the FISH slide to see whether there is
clustering of cell types, or differences in morphology between the different cell types. Then
scan the marked target area on the FISH slide using the 10x objective to find areas which
appear to be targeted cells and switch to a higher objective for confirmation and then ana‐
lyse using appropriate filter. Consideration of accidental analysis of non-target cells must al‐
so be taken into account when interpreting such cases, therefore increasing the number of
cells or sites analysed will increase the accuracy of the analysis. Alternatively, it may be pos‐
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sible to get a pathologist to mark several smaller sites containing only target cells, as this re‐
duces the risk of error before beginning the analysis.
Problem: Target area marked is very small, so it is difficult to test a variety of areas.
[Step 8]
Solution: While this makes analysis difficult, switching to the 10x objective and moving the
stage to a different position will reduce the likelihood of reanalyzing the same cells. Numer‐
ical scoring is also preferable in such a case, as it provides a reliable basis for interpretation.
Problem: The cells are highly dispersed or highly clustered, making analysis difficult.
[Step 8]
Solution: Select good areas where the cells are not overlapping using the DAPI filter and use
numerical scoring of individual cell signal patterns (this may mean increasing the number of
sites examined if the cells are widely dispersed). If a gene rearrangement probe is being
used, it may be sufficient just to report the presence or absence of a rearrangement without
doing individual cell analysis.
Problem: Distinguishing between real loss and gain of signal compared to artefact.
[Step 8]
Solution: If the target abnormality is either a gain (trisomy/tetrasomy) or loss (deletion) of a
signal, it pays to establish thresholds using normal control slides to estimate the level of ar‐
tefactual gain or loss of signal, and to check the manufacturer’s product information to see if
splitting of the probe or non-target binding/polymorphisms are common with the probe.
The variance in the signal patterns can also be checked – if the percentage of cells showing a
1R2G signal pattern is roughly equivalent to those showing a 2R1G signal, then it is reasona‐
ble to assume that it is due to artefactual truncation of signal.
Problem: There is discordance between analysts.
[Step 8]
Solution: Get a third analyst to score the sample. If two analysts have similar results, discard
the third analysis, or if all three give different results, take an average of all three results to al‐
low robust interpretation. If the three results differ hugely, it is preferable to confirm the result
with a secondary probe where possible, or request a repeat sample from another block. Where
the interpretation is still not clear, the case can be reported as inconclusive or failed.
Problem: A low level abnormality, multiple clones or mosaicism is suspected.
[Step 8]
Solution: Where the result is not straightforward use quantitative scoring and use appro‐
priate thresholds for interpretation. Paraffin FISH is not the most suitable method of de‐
tection for these cases, although methods that involve taking thicker slices of the section
have been developed [12].
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4. Conclusion
The role of pathologists is crucial to the analysis of paraffin FISH sections from the begin‐
ning of the process. They can help to eliminate very basic laboratory errors, such as identify‐
ing whether incorrect tissue has been sent prior to processing the slides, and can also help to
identify the appropriate target tissue within the paraffin section prior to analysing the sam‐
ple, so that inappropriate tissues can be reduced or eliminated. When analysing products of
conception, the fetal component can be very small compared to the maternal component,
and without guidance of pathologists, an erroneous result may occur. Similarly, in breast
cancer samples, it is important to eliminate areas of contained carcinoma (in situ compo‐
nents such as DCIS and LCIS) and lymphocytes, as these may result in false positive or neg‐
ative results, which can be deleterious if treatments such as Herceptin are then withheld
from the patient. Some samples such as lymphomas or graft versus host disease may require
extensive guidance from pathologists as knowledge of the disease characteristics will allow
for highly targeted analysis. In follicular lymphoma, the follicles need to be identified so
that centrocytes and centroblasts are targeted for analysis, and normal lymphocytes and re‐
active cells are avoided when analysing the sample (Swerdlow et al. 2008). For this reason, it
is best to include a variety of areas to get a representative result. It should be noted that ex‐
ternal quality assurance programmes may differ in the number of sites required for analysis.
Generally speaking, fewer sites are required, if initially the non-target tissue is eliminated.
Figure 10. Artefactual signal changes on suspension FISH slides.
Despite such assistance however, care must also be taken during the analysis of paraffin
samples, as in many cases it is impossible to completely remove the non-target tissue from
the area of interest. It is therefore important to check the H+E slide before beginning the
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analysis, as this will give an indication as to whether the sample is made up solely of target
tissue, or whether it contains a mixture of target and non-target tissue that must be taken
into account when making the final interpretation.
Figure 11. Artefactual considerations for paraffin FISH samples - truncation and overlapping of cells in specimen.
Figure 12. The need for thresholds for paraffin FISH analysis.
Due to both the potential for analysis of the incorrect target cells as outlined, and the artefac‐
tual variation that can arise when using the FISH technique [13], it is necessary to establish
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robust thresholds to guide the interpretation of results. Signal pattern changes can occur due
to poor hybridization of probe, background ‘rubbish-autofluorescence’ or ‘accidental over‐
lap’ of red and green signals (Figure 10).
These can lead to the appearance of false or atypical signal patterns; therefore thresholds
need to be established to distinguish between false positives and negatives. Paraffin anal‐
ysis  requires  higher  thresholds  than those for  suspension cultures,  as  there  is  the  addi‐
tional  complication of  overlap and truncation of  cells  [1,12],  causing artefactual  gain  or
loss of signals (Figures 11 and 12).
Thresholds are of particular importance when dealing with cases that show atypical, non-tar‐
get (e.g. unexpected loss or increase of copy number instead of a gene rearrangement) or low
level abnormalities, or those where mosaicism or multiple clones appear to be present, as it is
unclear in most cases as to how they may impact on patient treatment. While paraffin FISH is
usually not the most appropriate way to deal with such cases, but when tissue is scarce or has
already been processed, it can sometimes be the only option for testing. Numerical scoring of
the tissue in such cases will give an indication of the major signal pattern(s) and the level of var‐
iation inherent in the tissue, particularly in tumours where there can be concurrent increase in
the ploidy level, together with loss or gain of the target loci. This will allow a judgment to be
made about whether the variation is likely to be artefactual or not, as false aneuploidies will
show almost equivalent levels of loss between target and control loci.
Due to the potential complexities of paraffin analysis, the use of both cytogenetic and patholo‐
gy external quality control programs such as the College of American Pathologists (CAP) and
Australasian Society of Cytogeneticists (ASoC) is recommended, as it allows quality issues to
be addressed from both the cytogenetic and pathology perspectives. This provides a balanced
perspective on the degree of analytical stringency that is required prior to releasing result.
Appendices
Materials
Reagents
Biotin and Digoxygenin
Bovine serum albumin (BSA) Deionised water
Enzyme reagent (Invitrogen cat #00-8401)
Ethanol (70%, 80% and 100%)
Heat pre-treatment solution pH7.0 (Invitrogen cat #00-8401)
Hybridisation buffer
Non ionic detergent: NP40 (Vysis 30-80482). Store in -20°C.
Phosphate Buffered Saline (PBS)
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0.01% pepsin/HCl solution
Purified H2O
DNA probes
Shandon Rapid-Chrome™ Frozen Section Staining kit
2X SSC/0.1% Tween20
0.4xSSC/0.3%Tween20 solution
2xSSC/0.01% Tween20 solution
Vectashield antifade mounting solution with 1.5μg/ml DAPI (Vector laboratories Cat #
H-1200). Store in the dark at 4°C.
Xylol
Equipment
Atlas cooler box
Blotting paper
Centrifuge –Heraeus Biofuge Pico
Coverslips (13mm diameter round, 22x22mm and 24 x 50mm)
Diamond pen or diamond-tipped engraver –Easy Marker Engraver (Taiwan)
Eppendorf tubes
Fix-resistant marker pen
Fluorescence microscope - Zeiss Axio Imager.M1 microscope, Zeiss Axioplan microscope,
Olympus BX60 fluorescence microscope
Glass coplin jars
H&E slide
Hotplate
Humidified box
Incubator – Contherm Scientific NZ
Parafilm
Pipettes (2 ul and 100ul)
Pipette tips
Poly-lysine slides (with tissue sections of 2-5μm thickness)
Rubber cement – Weldtite Vulcanising Rubber Solution
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Safety goggles
Scalpel
Scissors
Slide drying racks
Thermal cycler – MJC Research PTC- 100 and PTC-200 Peltier Thermal Cyclers
Transmitted light microscope (Zeiss)
Fine tweezers (2 pairs)
Water bath – Grant Instruments (Cambridge)
Recipes
Biotin- and Avidin-conjugated antibodies
Store antibodies as 20μl aliquots at 4°C in sterile eppendorf tubes. Do not freeze.
Texas Red Avidin DCS (Biotek/Vector Laboratories Cat #A-2016).
Add 0.5ml of MilliQ water to 1mg lyophilised antibody for a final concentration of 2mg/ml.
Fluorescein Avidin DCS (Cell sorter grade), (Biotek/Vector Laboratories Cat #A-2011).
2mg/ml stock solution aliquotted at 20μl and stored in the dark at 4°C. Dilute 1:400 in
4xSSC/1% BSA immediately prior to use.
Biotinylated goat anti-avidin D (Biotek/Vector Laboratories Cat #BA0300).
Add 1ml of MilliQ water to 0.5mg lyophilised antibody for a final concentration of
0.5mg/ml.
Bovine Serum albumin (BSA)
1% BSA in 4xSSC. Dissolve 0.25g of BSA (Sigma A-7030) in 25ml 4xSSC pH 7.0. Store at 4°C
for up to 1 month.
FITC– conjugated anti-digoxygenin antibodies
Store antibodies as 50μl aliquots at 4°C in sterile eppendorf tubes. Do not freeze.
Anti-digoxigenin-fluorescein, FAB fragments (Boehringer Mannheim Cat #1207741).
Add 1ml of MilliQ water to 200μg lyophilised antibody for a final concentration of
0.2mg/ml.
Rabbit fluorescein anti-sheep IgG(H+L) (Biotek/Vector Laboratories Cat #FI-6000).
Add 1ml of MilliQ water to 1.5mg lyophilised antibody for a final concentration of
1.5mg/ml.
Goat fluorescein anti-rabbit IgG(H+L) (Biotek/Vector Laboratories Cat #FI-1000).
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Add 1ml of MilliQ water to 1.5mg lyophilised antibody for a final concentration of
1.5mg/ml.
Ethanol 100% Molecular biology grade.
Ethanol 80% Mix ethanol absolute (molecular biology grade) and distilled water in a 4:1
ratio (v/v).
Ethanol 70% Mix ethanol absolute (molecular biology grade) and distilled water in a 7:3
ratio (v/v).
Hydrochloric acid (HCl)
0.2M HCl. Add 2.4ml of 5N HCl to 60mls of MilliQ water.
0.01N HCI. Add 1mL of 5N HCl to 499mLs of distilled water. Store at room temperature for
up to 1 year.
Phosphate buffered saline (PBS)
1xPBS. Ca++ and Mg++ free. Dissolve 8.0g sodium chloride, 0.2g potassium chloride, 2.89g
Na2HPO4.12H20 and 0.2g KH2PO4 in order in 750ml of MilliQ water. Adjust the volume to 1
litre and autoclave. Store at room temperature.
Pre-treatment reagents for paraffin embedded tissue – Zymed (Invitrogen) Spot-
light™HER2 CISH kit (84-0146)
Reagent A. 1 litre of heat pretreatment solution, pH 7.0 (Ready-To-Use).
Reagent B. 5 ml of enzyme pretreatment reagent (Ready-To-Use).
Saline sodium citrate (SSC)
20xSSC (7.0). Dissolve 175.3g sodium chloride and 88.2g trisodium citrate in 800ml MilliQ
water. (or use SSC that comes with the Vysis kits; add 4 bottles to make 1L), pH to 7.0 and
adjust the final volume to 1 litre. Autoclave and store at room temperature.
4xSSC (pH7.0). Add 200ml of 20xSSC to 700ml MilliQ water. pH to 7.0 and adjust the final
volume to 1 litre. Autoclave and store at room temperature.
4XSSC/0.05% Tween20. Add 500μl Tween20 to 1 litre of 4xSSC. Mix well.
2XSSC/0.1% NP40. Add 1mL of NP40 to 1L of 2XSSC (pH7.0)
2xSSC (pH7.0). Add 100ml 20xSSC (pH 7.0) to 800ml MilliQ water. pH to 7.0 and adjust the
final volume to 1 litre. Autoclave and store at room temperature.
1xSSC (pH 7.0). Add 50ml of 20xSSC (pH 7.0) to 950ml of milliQ water. Adjust the pH to 7.0,
autoclave and store at room temperature.
0.4XSSC/0.3% NP40 (Quickwash buffer). Add 20ml of 20xSSC and 3ml of NP40 to 900ml
MilliQ water. Adjust the pH to 7.0 and final volume to 1 litre. Store at room temperature.
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Caution
All reagents are potentially hazardous. Appropriate safety procedures must be followed
when handling these materials. Avoid contact with skin and mucous membranes, and heat‐
ing of slides should be performed in a fume hood, as formalin fixed specimens may produce
toxic fumes when heated during processing. For more information consult the Hazardous
Substances Data Bank (HSDB) - http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB.
Formamide: perform steps involving formamide in hood to avoid inhalation of fumes
Xylene: perform steps involving xylene in hood to avoid inhalation of fumes
Commercial probes and hybridisation buffer solutions: Wear gloves at all times, and when
co-denaturing probes use a fume hood, as formamide may be present in probe mixtures and
give off toxic fumes.
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